limestone has been researched along with Hyperparathyroidism, Secondary in 93 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 15 (16.13) | 18.7374 |
1990's | 32 (34.41) | 18.2507 |
2000's | 36 (38.71) | 29.6817 |
2010's | 9 (9.68) | 24.3611 |
2020's | 1 (1.08) | 2.80 |
Authors | Studies |
---|---|
Bansal, N; Bishnoi, A; Katyal, A; Nachankar, A | 1 |
Baretta, GA; Cambi, MP; Mendes, SA; Rodrigues, AL | 1 |
Hong, YA; Hwang, SY; Jung, MY; Kang, BH; Kim, JY; Ko, GJ; Kwon, YJ; Lee, EA; Lee, JB; Lee, JE; Pyo, HJ | 1 |
Hamada, C; Hasegawa, H; Higuchi, C; Hiramatsu, M; Hosoya, T; Itami, N; Kasai, K; Kawaguchi, Y; Kawanishi, H; Kubota, M; Masakane, I; Minakuchi, J; Mitarai, T; Nakao, T; Suzuki, H; Tomo, T; Yamamoto, H | 1 |
De Vos, JY; Elseviers, M | 1 |
Hutchison, AJ; Mohammed, I | 1 |
Elashoff, RM; Gales, B; Harkins, GC; Jüppner, H; Sahney, S; Salusky, IB; Wang, HJ; Wesseling-Perry, K | 1 |
Fujimori, A; Fukushima, S; Itoh, H; Mizukami, K; Nara, H; Okada, M; Sanagi, M; Takakura, K; Terai, K | 1 |
Inaguma, D; Tatematsu, M | 1 |
Chew, D; Kidder, AC | 1 |
Elashoff, R; Gales, B; Jüppner, H; Pereira, RC; Sahney, S; Salusky, IB; Wang, HJ; Wesseling-Perry, K | 1 |
Ahokas, RA; Bhattacharya, SK; Komolafe, BO; McGee, JE; Moten, M; Weber, KT; William Rosenberg, E; Zia, AA | 1 |
Anastasilakis, AD; Makras, P; Polyzos, SA; Terpos, E | 1 |
Jean, G | 1 |
Martínez, AI; Milán, JA; Salgueira, M | 1 |
Audran, M; Chappard, D; Hoppé, E; Laffitte, A; Masson, C | 1 |
February, M; Geary, C; Moreira, A | 1 |
Burke, SK; Cozzolino, M; Dusso, AS; Finch, J; Liapis, H; Lu, Y; Slatopolsky, E | 1 |
Castro, R; Ferreira, C; Herman, A; Nunes-Azevedo, J; Oliveira, M; Travassos, F | 1 |
Martin, CJ; Reams, SM | 1 |
Butani, L; Jain, A | 1 |
Balducci, A; Coen, G; Curic, S; D'Haese, PC; De Broe, ME; Dimkovic, N; Djukanovic, L; Ferreira, A; Freemont, TJ; Hutchison, A; Pejanovic, S; Popovic, M; Sikole, A; Spasovski, GB; Sulkova, S; Sulowicz, W; Swanepoel, C; Torres, A | 1 |
Amor, J; Aresté, N; Cambil, T; Gómez, O; Páez, C; Palma, A; Salgueira, M; Sánchez-Palencia, R | 1 |
Alhejaili, F; Clement, L; Heidenheim, AP; Kortas, C; Leitch, R; Lindsay, RM; Nesrallah, G | 1 |
Burke, SK; Cozzolino, M; Dusso, AS; Finch, J; Liapis, H; Slatopolsky, E; Staniforth, ME | 1 |
Fukui, M; Hamada, C; Hayashi, K; Ishiguro, C; Koizumi, M; Osada, S; Sakamoto, T; Shou, I; Tomino, Y | 1 |
Antonen, JA; Hannula, PM; Jolma, PM; Kalliovalkama, J; Kööbi, P; Olander, RM; Pörsti, IH; Saha, HH | 1 |
González, A; Martín, F; Martínez, F; Sarró, F; Verdú, J | 1 |
Hoshino, J; Takaichi, K; Ubara, Y | 1 |
Tominaga, Y | 1 |
Benador, N; Greenbaum, LA; Grenda, R; Melnick, JZ; Paredes, A; Qiu, P; Restaino, I; Salusky, IB; Williams, LA; Wojtak, A | 1 |
Kinugasa, E; Koiwa, F; Ogata, H; Shishido, K | 1 |
Fukagawa, M; Kurihara, T; Kurosawa, T; Nishi, H; Sato, T | 1 |
Baba, S; Fujita, T; Hidai, H; Hyodo, T; Sakai, T; Taira, T; Takemura, T; Tsuchida, M; Wakai, H; Yoshida, K | 1 |
Hashimoto, N; Koike, T; Miyata, M; Mochizuki, T; Sato, N | 1 |
Mano, T; Onodera, Y; Yokoyama, T | 1 |
Eriguchi, R; Satou, Y; Takei, S | 1 |
Yumita, S | 1 |
Bellinghieri, G; Calò, LA; Monardo, P; Santoro, D; Savica, V | 1 |
Rees, L; Ridout, D; Waller, S | 1 |
Date, T; Funakoshi, S; Hashiguchi, J; Itoh, K; Kono, T; Kubo, H; Masaki, K; Nakano, H; Shigematsu, T; Tanaka, M; Uchino, J | 1 |
Harter, H; Horst, R; Martin, KJ; Slatopolsky, E; Thielan, J; Weerts, C | 1 |
Bignardi, L; Bono, F; Cambi, V; Gardini, F; Zanelli, P | 1 |
Barsotti, G; Ciardella, F; Giannoni, A; Giovannetti, S; Guiducci, A; Lupetti, S; Morelli, E | 1 |
Blaney, BJ; Gartner, RJ; Glanville, RJ; McKenzie, RA | 1 |
Aparicio, M; Blanchetier, V; Bouchet, JL; Combe, C; de Précigout, V; Fournier, A; Morel, D; Potaux, L | 1 |
Tsukamoto, Y | 1 |
Agbomson, F; Brazier, M; Chauvenet, M; Garabedian, M; Maamer, M; Sebert, JL | 1 |
Armstrong, A; Cunningham, J | 1 |
Izumida, I; Morishita, T; Moriya, R; Nagaba, Y; Okubo, M; Tsukamoto, Y | 1 |
Henderson, IS; Jones, MC; McElduff, N; Pflanz, S | 1 |
Bacchella, L; Bellazzi, R; de Vincenzi, A; Gazo, A; Gini, A; Nai, M; Romanini, D; Santagostino, M | 1 |
Bonforte, G; Dozio, B; Scanziani, R; Surian, M | 1 |
Bourgeon, B; Chapuy, M; el Esper, N; Farquet, C; Gheerbrant, J; Judith, D; Moriniere, P; Pamphile, R; Van Orshoven, A; Viron, B | 1 |
Kinosita, Y; Kuno, T; Nagura, Y; Okada, K; Takahashi, S; Yanai, M | 1 |
Almaraz-Jimenez, M; Gomez-Fernandez, P; Perez-Mijares, R; Ramos-Diaz, M; Rivero-Bohorquez, J | 1 |
Fournier, A | 1 |
Baldwin, D; Ball, E; Marsden, J; Moniz, C; Parsons, V; Rifkin, I | 1 |
Ali, AA; Baillod, RA; Moorhead, JF; Sweny, P; Varghese, Z | 1 |
Brown, A; Freeman, J; Johnson, DW; McIntyre, HD; Rigby, RJ | 1 |
Chapuy, MC; Chapuy, P; Hazard, MC; Meunier, PJ; Thomas, JL | 1 |
Adu, D; Bhalla, C; Cochrane, T; Duncan, R; Michael, J; Richards, NT | 1 |
Barreneche, M; Graciela Garcia, M; Leanza, H; Najun Zarazga, C | 1 |
Janssen, MJ; ter Wee, PM; van Boven, WP; van der Kuy, A | 2 |
Corradi, B; Imbasciati, E; Malberti, F | 1 |
Brandi, L; Daugaard, H; Egsmose, C; Jensen, LT; Nielsen, PK; Olgaard, K | 1 |
Porges, WL; Watson, AD | 1 |
Chahin, J; Coronel, F; Gallego, E; García, J; Herrero, JA; Macia, M; Méndez, ML; Navarro, JF | 1 |
Novikov, AI | 1 |
Barsotti, G; Barsotti, M; Cozza, V; Cupisti, A; Giovannetti, S; Meola, M; Morelli, E | 1 |
Bleyer, AJ; Burke, SK; Chertow, GM; Dillon, M; Domoto, DT; Garrett, BN; Slatopolsky, E; Steg, M; Wilkes, BM; Wombolt, DG | 1 |
Brandi, L; Bro, S; Daugaard, H; Nielsen, PK; Olgaard, K | 1 |
Marc n, R; Orofino, L; Ortuño, J; Rivera, M; Rodríguez, JR; Tenorio, MT; Teruel, JL | 1 |
Fukagawa, M | 1 |
Indridason, OS; Quarles, LD | 1 |
Hara, S; Imai, T; Inoue, S; Katori, H; Kitamura, A; Kuzuhara, K; Matsushita, Y; Tagami, T; Takagawa, R; Takemoto, F; Ubara, Y; Yamada, A; Yokota, M | 1 |
Llach, F; Yudd, M | 1 |
Baló-Bangat, JM; Mako, J; Scharrer, K; Vajda, A | 1 |
Albert, A; Collette, J; Deroisy, R; Jupsin, I; Reginster, JY | 1 |
Johnston, JR; Muhammedi, MA; Piraino, B; Puschett, JB; Rault, R | 1 |
Mörsky, P; Mustonen, J; Pasternack, A; Pietilä, K; Reinikainen, P; Saha, H; Seppälä, E | 1 |
Altmann, P; Cunningham, J; Marsh, F; Noonan, K; Sawyer, N | 1 |
Koivula, T; Mörsky, P; Mustonen, J; Pasternack, A; Pietilä, K; Seppälä, E | 1 |
Hatano, M; Nagura, Y; Okada, K; Takahashi, S | 1 |
Belbrik, S; Boudaillez, B; Fournier, A; Hocine, C; Marie, A; Moriniere, P; Renaud, H; Westeel, PF | 1 |
Malberti, F; Minoia, C; Poggio, F; Salvadeo, A; Surian, M | 1 |
Bartholomay, DW; Davidai, GA; Lobaugh, B; Quarles, LD; Schwab, SJ | 1 |
Chantler, C; Compston, J; Haycock, GB; Mak, RH; Mellish, RW; Turner, C; Vedi, S | 1 |
Fournier, A; Morinière, P; Renaud, H | 1 |
Chantler, C; Haycock, GB; Mak, RH; Powell, H; Thompson, T; Turner, C | 1 |
Bataille, P; Fournier, A; Grégoire, I; Guéris, J; Hervé, M; Leflon, A; Morinière, P; Sebert, JL | 1 |
Marsac, J; Meyrier, A; Richet, G | 1 |
14 review(s) available for limestone and Hyperparathyroidism, Secondary
Article | Year |
---|---|
Oral phosphate binders for the management of serum phosphate levels in dialysis patients.
Topics: Acetates; Administration, Oral; Aluminum Hydroxide; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Chelating Agents; Drug Monitoring; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Magnesium; Nephrology; Patient Education as Topic; Phosphorus; Polyamines; Practice Guidelines as Topic; Renal Dialysis; Sevelamer; Treatment Outcome | 2009 |
[Chronic kidney disease (CKD) and bone. Chronic kidney disease--mineral and bone disorder in predialysis patients].
Topics: Bone Diseases, Metabolic; Calcium Carbonate; Chronic Disease; Dialysis; Disease Progression; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Kidney Diseases; Phosphorus; Vitamin D; Vitamin D Deficiency | 2009 |
Treatment options for hyperphosphatemia in feline CKD: what's out there?
Topics: Animals; Calcium Carbonate; Cat Diseases; Cats; Chelating Agents; Diet; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Failure, Chronic; Parathyroid Hormone; Phosphates; Phosphorus; Prognosis | 2009 |
Paget's disease of bone and calcium homeostasis: focus on bisphosphonate treatment.
Topics: 25-Hydroxyvitamin D 2; Bone Density Conservation Agents; Calcifediol; Calcium Carbonate; Dietary Supplements; Diphosphonates; Drug Monitoring; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Osteitis Deformans; Osteomalacia; Vitamin D | 2011 |
[How to manage mineral metabolism disorders in renal failure].
Topics: Aged; Alkaline Phosphatase; Bone Density; Calcimimetic Agents; Calcitriol; Calcium Carbonate; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Combined Modality Therapy; Diabetic Nephropathies; Female; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Failure, Chronic; Male; Parathyroid Hormone; Phosphorus, Dietary; Predictive Value of Tests; Renal Replacement Therapy | 2011 |
[Clinical evidence and treatment for optimum concentration of parathyroid hormone, calcium and phosphate in chronic renal failure].
Topics: Calcinosis; Calcium; Calcium Carbonate; Calcium, Dietary; Chronic Kidney Disease-Mineral and Bone Disorder; Epoxy Compounds; Evidence-Based Medicine; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Parathyroid Hormone; Phosphorus; Phosphorus, Dietary; Polyamines; Polyethylenes; Practice Guidelines as Topic; Sevelamer | 2004 |
[Clinical practice guidelines for severe renal hyperparathyroidism].
Topics: Biomarkers; Calcium Carbonate; Diagnostic Imaging; Humans; Hydroxycholecalciferols; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Phosphorus Metabolism Disorders; Practice Guidelines as Topic; Severity of Illness Index; Thyroid Gland; Transplantation, Autologous | 2004 |
Phosphate binders and management of hyperphosphataemia in end-stage renal disease.
Topics: Acetates; Aluminum Compounds; Bone Diseases, Metabolic; Calcinosis; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Central Nervous System Diseases; Chronic Kidney Disease-Mineral and Bone Disorder; Diet, Protein-Restricted; Ferric Compounds; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Lanthanum; Phosphates; Phosphorus, Dietary; Polyamines; Renal Dialysis; Sevelamer | 2006 |
Pathophysiology and treatment of secondary hyperparathyroidism in patients with chronic renal failure.
Topics: Administration, Oral; Animals; Calcitriol; Calcium Carbonate; Diet; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Parathyroid Hormone | 1995 |
The treatment of metabolic bone disease in patients on peritoneal dialysis.
Topics: Aluminum Compounds; Bone Diseases, Metabolic; Calcium Carbonate; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Peritoneal Dialysis, Continuous Ambulatory; Phosphates; Uremia; Vitamin D | 1994 |
[Methods of correcting hyperphosphatemia in chronic renal failure and in dialysis (review)].
Topics: Aluminum Hydroxide; Antacids; Calcitriol; Calcium; Calcium Carbonate; Diet; Dose-Response Relationship, Drug; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Parathyroid Hormone; Phosphates; Renal Dialysis | 1997 |
[Physiopathology and therapy of renal osteodystrophy and secondary hyperparathyroidism].
Topics: Animals; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Parathyroid Hormone; Parathyroidectomy; Receptors, Calcitriol; Vitamin D | 1999 |
Current medical management of secondary hyperparathyroidism.
Topics: Acetates; Administration, Oral; Calcitriol; Calcium; Calcium Carbonate; Calcium Compounds; Ethanol; Humans; Hyperparathyroidism, Secondary; Injections, Intravenous; Intestinal Absorption; Kidney Failure, Chronic; Magnesium Compounds; Parathyroid Hormone; Parathyroidectomy; Phosphates; Phosphorus, Dietary | 2000 |
1,25 (OH)2 vitamin D3 deficiency and renal osteodystrophy: should its well-accepted pathogenetic role in secondary hyperparathyroidism lead to its systematic preventive therapeutic use?
Topics: Calcitriol; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Vitamin D Deficiency | 1987 |
27 trial(s) available for limestone and Hyperparathyroidism, Secondary
Article | Year |
---|---|
SECONDARY HYPERPARATHYROIDISM AFTER BARIATRIC SURGERY: TREATMENT IS WITH CALCIUM CARBONATE OR CALCIUM CITRATE?
Topics: Adult; Aged; Bariatric Surgery; Calcium Carbonate; Calcium Citrate; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Prospective Studies | 2015 |
Response of different PTH assays to therapy with sevelamer or CaCO3 and active vitamin D sterols.
Topics: Adolescent; Adult; Alkaline Phosphatase; Calcium; Calcium Carbonate; Chelating Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Hyperparathyroidism, Secondary; Immunoassay; Male; Parathyroid Hormone; Phosphorus; Polyamines; Renal Dialysis; Sevelamer; Vitamin D | 2009 |
Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism.
Topics: Adolescent; Bone and Bones; Bone Density Conservation Agents; Calcitriol; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Drug Therapy, Combination; Ergocalciferols; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Failure, Chronic; Longitudinal Studies; Male; Osteogenesis; Parathyroid Hormone; Polyamines; Sevelamer | 2011 |
A multicenter study on the effects of lanthanum carbonate (Fosrenol) and calcium carbonate on renal bone disease in dialysis patients.
Topics: Adult; Aged; Biomarkers; Bone and Bones; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Phosphates; Renal Dialysis | 2003 |
[Early treatment of secondary hyperparathyroidism in moderate renal insufficiency: low-phosphorus diet versus calcium carbonate].
Topics: Aged; Calcifediol; Calcitriol; Calcium; Calcium Carbonate; Calcium, Dietary; Chelating Agents; Chelation Therapy; Creatinine; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Phosphorus, Dietary; Treatment Outcome | 2003 |
Calcium and phosphate balance with quotidian hemodialysis.
Topics: Adult; Aged; Alkaline Phosphatase; Appointments and Schedules; Calcium; Calcium Carbonate; Female; Follow-Up Studies; Hemodialysis Solutions; Hemodialysis, Home; Humans; Hyperparathyroidism, Secondary; Isoenzymes; Kidney Failure, Chronic; Male; Middle Aged; Ontario; Parathyroid Hormone; Phosphates; Prospective Studies; Treatment Outcome | 2003 |
Intravenous calcitriol for treatment of hyperparathyroidism in children on hemodialysis.
Topics: Acetates; Adolescent; Calcitriol; Calcium; Calcium Carbonate; Calcium Channel Agonists; Calcium Compounds; Child; Child, Preschool; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Humans; Hyperparathyroidism, Secondary; Injections, Intravenous; Kidney Failure, Chronic; Male; Parathyroid Hormone; Phosphates; Renal Dialysis | 2005 |
Control of parathyroid function in patients with a short history of hemodialysis.
Topics: Administration, Oral; Calcitriol; Calcium; Calcium Carbonate; Female; Follow-Up Studies; Humans; Hydroxycholecalciferols; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Prospective Studies; Renal Dialysis; Time Factors | 2005 |
[Clinical analysis of time-course changes in minerals and parathyroid hormone levels during treatment with phosphate binders in hemodialysis patients with secondary hyperparathyroidism].
Topics: Aged; Calcium; Calcium Carbonate; Drug Therapy, Combination; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Polyamines; Renal Dialysis; Sevelamer; Time Factors | 2005 |
[Sevelamer hydrochloride and K/DOQI guidelines].
Topics: Alkaline Phosphatase; Calcium; Calcium Carbonate; Cholecalciferol; Chronic Kidney Disease-Mineral and Bone Disorder; Dialysis; Drug Therapy, Combination; Female; Humans; Hyperparathyroidism, Secondary; Male; Parathyroid Hormone; Phosphorus; Polyamines; Practice Guidelines as Topic; Sevelamer | 2005 |
Bone mineral density in children with chronic renal failure.
Topics: Absorptiometry, Photon; Adolescent; Bone Density; Bone Density Conservation Agents; Calcium; Calcium Carbonate; Child; Child, Preschool; Cohort Studies; Female; Glomerular Filtration Rate; Humans; Hydroxycholecalciferols; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Parathyroid Hormone; Phosphates | 2007 |
Comparison of sevelamer hydrochloride with colestimide, administered alone or in combination with calcium carbonate, in patients on hemodialysis.
Topics: Adult; Aged; Calcium; Calcium Carbonate; Chelating Agents; Drug Therapy, Combination; Epichlorohydrin; Female; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Imidazoles; Japan; Kidney Failure, Chronic; Male; Middle Aged; Phosphorus; Polyamines; Prospective Studies; Renal Dialysis; Resins, Synthetic; Sevelamer | 2008 |
Evaluation of a new solid formulation of calcium and vitamin D in institutionalized elderly subjects. A randomized comparative trial versus separate administration of both constituents.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Calcium; Calcium Carbonate; Cholecalciferol; Creatinine; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hydroxycholecalciferols; Hyperparathyroidism, Secondary; Male; Parathyroid Hormone; Vitamin D Deficiency | 1995 |
Effect of administering calcium carbonate to treat secondary hyperparathyroidism in nondialyzed patients with chronic renal failure.
Topics: Administration, Oral; Calcitriol; Calcium; Calcium Carbonate; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Time Factors | 1995 |
Calcium acetate versus calcium carbonate as phosphate-binding agents in chronic haemodialysis.
Topics: Acetates; Acetic Acid; Adult; Aged; Calcium; Calcium Carbonate; Cross-Over Studies; Drug Tolerance; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Patient Compliance; Phosphates; Renal Dialysis | 1994 |
A randomized trial comparing 1.25 mmol/l calcium dialysate to 1.75 mmol/l calcium dialysate in CAPD patients.
Topics: Aluminum Hydroxide; Bone Density; Calcitriol; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Dialysis Solutions; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Male; Middle Aged; Osteocalcin; Parathyroid Hormone; Peritoneal Dialysis, Continuous Ambulatory; Phosphates; Prospective Studies | 1996 |
Biochemical effects of calcium and vitamin D supplementation in elderly, institutionalized, vitamin D-deficient patients.
Topics: Administration, Oral; Age Factors; Aged; Aged, 80 and over; Alkaline Phosphatase; Calcium; Calcium Carbonate; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Institutionalization; Male; Parathyroid Hormone; Retrospective Studies; Vitamin D; Vitamin D Deficiency | 1996 |
Calcium acetate versus calcium carbonate and erythropoietin dosages in haemodialysis patients.
Topics: Acetates; Analysis of Variance; Anemia; Calcium; Calcium Carbonate; Drug Administration Routes; Erythropoietin; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Male; Parathyroid Hormone; Prospective Studies; Renal Dialysis; Uremia | 1995 |
Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients.
Topics: Acetates; Acetic Acid; Aluminum Hydroxide; Calcium Carbonate; Drug Administration Schedule; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Patient Compliance; Phosphates; Prospective Studies; Renal Dialysis; Time Factors | 1996 |
Long-term effects of intravenous 1 alpha (OH)D3 combined with CaCO3 and low-calcium dialysis on secondary hyperparathyroidism and biochemical bone markers in patients on chronic hemodialysis.
Topics: Adult; Alkaline Phosphatase; Aluminum; Biomarkers; Bone and Bones; Bone Density; Calcium; Calcium Carbonate; Chronic Disease; Dialysis Solutions; Diaphyses; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Femur Neck; Humans; Hydrogen-Ion Concentration; Hydroxycholecalciferols; Hyperparathyroidism, Secondary; Injections, Intravenous; Lumbar Vertebrae; Male; Middle Aged; Osteocalcin; Parathyroid Hormone; Peptide Fragments; Phosphates; Phosphorus; Procollagen; Radiography; Renal Dialysis | 1996 |
Calcium salts of keto-amino acids, a phosphate binder alternative for patients on CAPD.
Topics: Administration, Oral; Aluminum Hydroxide; Amino Acids; Calcium Carbonate; Chelating Agents; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Phosphates | 1997 |
Secondary hyperparathyroidism in severe chronic renal failure is corrected by very-low dietary phosphate intake and calcium carbonate supplementation.
Topics: Adult; Aged; Amino Acids; Antacids; Apolipoproteins B; Calcium; Calcium Carbonate; Cholesterol; Creatinine; Diet, Protein-Restricted; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Magnesium; Male; Middle Aged; Parathyroid Hormone; Phosphates; Phosphorus, Dietary; Triglycerides; Urea; Vitamin D | 1998 |
A randomized trial of sevelamer hydrochloride (RenaGel) with and without supplemental calcium. Strategies for the control of hyperphosphatemia and hyperparathyroidism in hemodialysis patients.
Topics: Calcium; Calcium Carbonate; Cholesterol; Female; Gels; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Polyamines; Sevelamer | 1999 |
Comparison of treatments for mild secondary hyperparathyroidism in hemodialysis patients. Durham Renal Osteodystrophy Study Group.
Topics: Alkaline Phosphatase; Calcitriol; Calcium Carbonate; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Patient Compliance; Phosphates; Prospective Studies; Renal Dialysis | 2000 |
Administration of a supplement containing both calcium and vitamin D is more effective than calcium alone to reduce secondary hyperparathyroidism in postmenopausal women with low 25(OH)vitamin D circulating levels.
Topics: Aged; Calcium Carbonate; Calcium Compounds; Carbonates; Drug Combinations; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Lactates; Middle Aged; Postmenopause; Prospective Studies; Vitamin D; Vitamin D Deficiency | 2002 |
Suppression of secondary hyperparathyroidism in children with chronic renal failure by high dose phosphate binders: calcium carbonate versus aluminium hydroxide.
Topics: Adolescent; Aluminum Hydroxide; Calcium Carbonate; Child; Child, Preschool; Clinical Trials as Topic; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Parathyroid Hormone; Phosphates; Random Allocation | 1985 |
Comparison of 1 alpha-OH-vitamin D3 and high doses of calcium carbonate for the control of hyperparathyroidism and hyperaluminemia in patients on maintenance dialysis.
Topics: Adult; Aged; Alkaline Phosphatase; Aluminum; Aluminum Hydroxide; Calcium; Calcium Carbonate; Female; Humans; Hydroxycholecalciferols; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Hormone; Phosphates; Random Allocation; Renal Dialysis; Time Factors; Uremia | 1985 |
52 other study(ies) available for limestone and Hyperparathyroidism, Secondary
Article | Year |
---|---|
Hungry bone syndrome like presentation following single-dose denosumab for hypercalcaemia secondary to sarcoidosis with IgA nephropathy.
Topics: Bone Diseases, Metabolic; Calcitriol; Calcium; Calcium Carbonate; Denosumab; Female; Glomerulonephritis, IGA; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hypocalcemia; Hypophosphatemia; Parathyroid Hormone; Sarcoidosis | 2022 |
Predicting postoperative total calcium requirements after parathyroidectomy in secondary hyperparathyroidism.
Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Biomarkers; Calcium; Calcium Carbonate; Calcium Compounds; Calcium Gluconate; Decision Support Techniques; Dietary Supplements; Female; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Lactates; Linear Models; Male; Middle Aged; Models, Biological; Multivariate Analysis; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Recurrence; Republic of Korea; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Young Adult | 2015 |
Differences in corrective mode for divalent ions and parathyroid hormone between standard- and low-calcium dialysate in patients on continuous ambulatory peritoneal dialysis--result of a nationwide survey in Japan.
Topics: Adult; Aged; Antacids; Calcium; Calcium Carbonate; Dialysis Solutions; Drug Prescriptions; Health Surveys; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hyperphosphatemia; Japan; Middle Aged; Parathyroid Hormone; Peritoneal Dialysis, Continuous Ambulatory; Phosphorus; Surveys and Questionnaires; Vitamin D; Vitamins | 2008 |
The use of phosphate binders: data from contributors to the European Practice Database.
Topics: Acetates; Aluminum Compounds; Analysis of Variance; Calcium Carbonate; Calcium Compounds; Chelating Agents; Cross-Sectional Studies; Databases, Factual; Dietetics; Drug Utilization; Europe; Health Care Surveys; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Lanthanum; Nephrology; Polyamines; Practice Patterns, Physicians'; Renal Dialysis; Sevelamer; Surveys and Questionnaires; Vitamin D | 2009 |
Vascular calcification and secondary hyperparathyroidism of severe chronic kidney disease and its relation to serum phosphate and calcium levels.
Topics: Adenine; Animals; Aortic Diseases; Biomarkers; Blood Urea Nitrogen; Calcinosis; Calcium; Calcium Carbonate; Chelating Agents; Cholecalciferol; Chronic Disease; Creatinine; Disease Models, Animal; Disease Progression; Hyperparathyroidism, Secondary; Hyperphosphatemia; Hypocalcemia; Kidney Diseases; Male; Parathyroid Hormone; Phosphates; Polyamines; Rats; Rats, Wistar; Sevelamer; Severity of Illness Index; Time Factors | 2009 |
Supplemental vitamin D and calcium in the management of African Americans with heart failure having hypovitaminosis D.
Topics: Black or African American; Calcium Carbonate; Calcium, Dietary; Cardiomyopathy, Dilated; Cholecalciferol; Dietary Supplements; Dinoprost; Ergocalciferols; Female; Heart Failure; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Hormone; Stroke Volume; Vitamin D; Vitamin D Deficiency | 2011 |
Regression of vascular calcification in a patient treated with cinacalcet: a case report.
Topics: Breast; Calcimimetic Agents; Calcitriol; Calcium Carbonate; Chelating Agents; Cinacalcet; Drug Therapy, Combination; Female; Graft Rejection; Hand; Humans; Hydroxycholecalciferols; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Mammography; Middle Aged; Naphthalenes; Nephritis, Interstitial; Phosphorus; Polyamines; Renal Dialysis; Reoperation; Sevelamer; Vascular Calcification | 2011 |
Osteomalacia in a patient with Paget's bone disease treated with long-term etidronate.
Topics: Aged, 80 and over; Alkaline Phosphatase; Biopsy; Bone Density Conservation Agents; Calcification, Physiologic; Calcium Carbonate; Cholecalciferol; Etidronic Acid; Female; Femoral Fractures; Fibula; Fractures, Spontaneous; Humans; Hyperparathyroidism, Secondary; Iatrogenic Disease; Osteitis Deformans; Osteolysis; Osteomalacia; Parathyroid Hormone; Radionuclide Imaging; Rib Fractures; Tibial Fractures; Ulna; Vitamin D | 2012 |
Parathyroid hormone levels in neonates with suspected osteopenia.
Topics: Biomarkers; Bone Diseases, Metabolic; Calcium Carbonate; Dietary Supplements; Female; Humans; Hyperparathyroidism, Secondary; Incidence; Infant, Extremely Low Birth Weight; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Parathyroid Hormone; Radiography; Retrospective Studies; Treatment Outcome | 2013 |
The effects of sevelamer hydrochloride and calcium carbonate on kidney calcification in uremic rats.
Topics: Animals; Antacids; Calcinosis; Calcium; Calcium Carbonate; Creatinine; Epoxy Compounds; Female; Hyperparathyroidism, Secondary; Kidney; Liver; Myocardium; Organ Size; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Polyamines; Polyethylenes; Rats; Rats, Sprague-Dawley; Sevelamer; Uremia | 2002 |
RenaGel efficacy in severe secondary hyperparathyroidism.
Topics: Adult; Aged; Aluminum; Aluminum Hydroxide; Calcium; Calcium Carbonate; Chelating Agents; Drug Costs; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Lipids; Male; Middle Aged; Parathyroid Hormone; Patient Selection; Phosphorus; Polyamines; Renal Dialysis; Sevelamer; Treatment Outcome | 2002 |
The renal dietitian's role in managing hyperphosphatemia and secondary hyperparathyroidism in dialysis patients: a national survey.
Topics: Acetates; Bone and Bones; Calcium Carbonate; Calcium Compounds; Dietetics; Epoxy Compounds; Ergocalciferols; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Phosphates; Phosphorus, Dietary; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer; Surveys and Questionnaires; Vitamin D | 2003 |
Severe hyperphosphatemia resulting from high-dose liposomal amphotericin in a child with leukemia.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Calcium Carbonate; Candidiasis; Cellulitis; Child; Drug Carriers; Female; Headache; Humans; Hyperparathyroidism, Secondary; Immunocompromised Host; Itraconazole; Liposomes; Mucormycosis; Orbital Diseases; Parathyroid Hormone; Phosphates; Phosphatidylcholines; Phosphatidylglycerols; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Seizures; Sinusitis; Vitamin D | 2003 |
Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia.
Topics: Animals; Aorta; Body Weight; Calcinosis; Calcium; Calcium Carbonate; Creatinine; Epoxy Compounds; Female; Hyperparathyroidism, Secondary; Kidney; Myocardium; Parathyroid Glands; Parathyroid Hormone; Phosphorus, Dietary; Polyamines; Polyethylenes; Proteinuria; Rats; Rats, Sprague-Dawley; Sevelamer; Time Factors; Uremia | 2003 |
Evaluation of parathyroid hyperplasia by ultrasonographic examination in patients with end-stage renal failure before and at initiation of dialysis.
Topics: Adult; Aged; Alkaline Phosphatase; Biomarkers; Calcium; Calcium Carbonate; Cholecalciferol; Dialysis; Female; Humans; Hyperparathyroidism, Secondary; Hyperplasia; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Glands; Parathyroid Hormone; Ultrasonography, Doppler, Color; Vitamins | 2003 |
Treatment of hyperphosphatemia, secondary hyperparathyroidism and hypocalcemia with calcium carbonate favorably modulates vaccination response in uremic rats.
Topics: Analysis of Variance; Animals; Antibodies, Bacterial; Calcium Carbonate; Calcium, Dietary; Creatinine; Hyperparathyroidism, Secondary; Hypocalcemia; Male; Nephrectomy; Phosphorus Metabolism Disorders; Rats; Rats, Sprague-Dawley; Statistics, Nonparametric; Tetanus Toxoid; Uremia | 2004 |
[MIBI and parathyroid gland function in secondary hyperparathyroidism].
Topics: Acetates; Adult; Aged; Calcitriol; Calcium; Calcium Carbonate; Calcium Compounds; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Radionuclide Imaging; Radiopharmaceuticals; Renal Dialysis; Secretory Rate; Technetium Tc 99m Sestamibi; Uremia | 2004 |
Combination therapy with sevelamer hydrochloride and calcium carbonate in Japanese patients with long-term hemodialysis: alternative approach for optimal mineral management.
Topics: Antacids; Bone and Bones; Bone Density; Calcium; Calcium Carbonate; Calcium, Dietary; Chronic Kidney Disease-Mineral and Bone Disorder; Drug Therapy, Combination; Epoxy Compounds; Humans; Hyperparathyroidism, Secondary; Japan; Kidney Failure, Chronic; Parathyroid Hormone; Phosphorus; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer; Time Factors | 2005 |
[Treatment of adynamic bone disease with the complete replacement from calcium carbonate to sevelamer hydrochloride].
Topics: Aged; Biomarkers; Bone Diseases, Metabolic; Calcium Carbonate; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Osteitis Fibrosa Cystica; Osteocalcin; Polyamines; Renal Dialysis; Sevelamer; Time Factors | 2005 |
[Defining the role of sevelamer chloride as a therapeutic agent for management of phosphate in patient with hemodialysis].
Topics: Aged; Calcium; Calcium Carbonate; Diet Therapy; Drug Therapy, Combination; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Phosphorus Metabolism Disorders; Polyamines; Renal Dialysis; Sevelamer; Vitamin D | 2005 |
[Control of calcium and phosphate in hemodialysis patients].
Topics: Calcium; Calcium Carbonate; Combined Modality Therapy; Diet Therapy; Female; Humans; Hyperparathyroidism, Secondary; Male; Parathyroid Hormone; Phosphorus; Polyamines; Practice Guidelines as Topic; Renal Dialysis; Sevelamer | 2005 |
Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.
Topics: Administration, Oral; Adult; Aged; Calcitriol; Calcium; Calcium Carbonate; Female; Humans; Hyperparathyroidism, Secondary; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Time Factors; Uremia | 1984 |
Prevention of complications of secondary hyperparathyroidism in long-term dialysis patients.
Topics: Adult; Calcium Carbonate; Creatinine; Humans; Hyperparathyroidism, Secondary; Middle Aged; Parathyroid Glands; Parathyroid Hormone; Renal Dialysis; Urea; Vitamin D | 1984 |
Reversal of hyperparathyroidism in severe uremics following very low-protein and low-phosphorus diet.
Topics: Adult; Aged; Amino Acids, Essential; Calcium; Calcium Carbonate; Calcium, Dietary; Dietary Proteins; Female; Humans; Hyperparathyroidism, Secondary; Keto Acids; Male; Middle Aged; Parathyroid Hormone; Phosphates; Phosphorus; Uremia | 1982 |
Control of nutritional secondary hyperparathyroidism in grazing horses with calcium plus phosphorus supplementation.
Topics: Animal Feed; Animals; Calcium Carbonate; Calcium Oxalate; Calcium Phosphates; Drug Combinations; Female; Horse Diseases; Horses; Hyperparathyroidism, Secondary; Male; Oxalates | 1981 |
Long-term control of hyperparathyroidism in advanced renal failure by low-phosphorus low-protein diet supplemented with calcium (without changes in plasma calcitriol).
Topics: Adult; Aged; Calcitriol; Calcium; Calcium Carbonate; Creatinine; Dietary Proteins; Female; Humans; Hyperparathyroidism, Secondary; Intestinal Absorption; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphates; Phosphorus; Retrospective Studies; Time Factors | 1995 |
Calcium mass balance and behavior of intact immunoreactive parathyroid hormone in acetate-free biofiltration: acute and one-year evaluation.
Topics: Acetates; Adult; Aged; Aluminum Hydroxide; Bicarbonates; Calcitriol; Calcium; Calcium Carbonate; Female; Follow-Up Studies; Hemodiafiltration; Hemodialysis Solutions; Humans; Hydrogen-Ion Concentration; Hyperparathyroidism, Secondary; Magnesium Hydroxide; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Secretory Rate; Uremia | 1994 |
Effects of calcitriol pulse therapy per os in CAPD patients.
Topics: Acetates; Acetic Acid; Administration, Oral; Adult; Aged; Calcitriol; Calcium Carbonate; Humans; Hyperparathyroidism, Secondary; Magnesium; Middle Aged; Parathyroid Hormone; Peritoneal Dialysis, Continuous Ambulatory | 1994 |
Improvement of severe secondary hyperparathyroidism in dialysis patients by intravenous 1 alpha(OH) vitamin D3, oral CaCO3 and low dialysate calcium.
Topics: Administration, Oral; Adult; Aged; Calcium; Calcium Carbonate; Dialysis Solutions; Female; Humans; Hydroxycholecalciferols; Hyperparathyroidism, Secondary; Injections, Intravenous; Male; Middle Aged; Phosphates; Renal Dialysis | 1993 |
Oral 1,25(OH)2D3 pulse therapy for the treatment of secondary hyperparathyroidism.
Topics: Administration, Oral; Adult; Calcitriol; Calcium Carbonate; Drug Administration Schedule; Humans; Hyperparathyroidism, Secondary; Middle Aged; Renal Dialysis | 1993 |
Treatment of severe secondary hyperparathyroidism with administration of calcium carbonate, intermittent high oral doses of 1,25-dihydroxyvitamin D3 and dialysate with 3 mEq/1 calcium concentration.
Topics: Adult; Calcitriol; Calcium; Calcium Carbonate; Drug Administration Schedule; Female; Hemodialysis Solutions; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Renal Dialysis; Time Factors | 1993 |
Hypercalcemia with calcium carbonate for uraemic hyperparathyroidism: consequence of a challenge overmet by the nephrologist?
Topics: Calcium Carbonate; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Peritoneal Dialysis, Continuous Ambulatory; Renal Dialysis; Uremia | 1993 |
Successful control of hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis using magnesium carbonate and calcium carbonate as phosphate binders.
Topics: Calcium; Calcium Carbonate; Dialysis Solutions; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Magnesium; Parathyroid Hormone; Peritoneal Dialysis, Continuous Ambulatory; Phosphates | 1993 |
Calcium set point progressively worsens in hemodialysis patients despite conventional oral 1-alpha hydroxycholecalciferol supplementation.
Topics: Administration, Oral; Bone Density; Calcium; Calcium Carbonate; Female; Humans; Hydroxycholecalciferols; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Renal Dialysis | 1993 |
Low calcium dialysate and hyperparathyroidism.
Topics: Adult; Aged; Alkaline Phosphatase; Calcium; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Combined Modality Therapy; Dialysis Solutions; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Parathyroidectomy; Peritoneal Dialysis, Continuous Ambulatory; Phosphates; Prospective Studies; Risk Factors | 1996 |
[Medical parathyroidectomy. Its efficacy in treatment of lower maxillary brown tumor].
Topics: Administration, Oral; Adult; Calcitriol; Calcium Carbonate; Granuloma, Giant Cell; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Mandibular Diseases; Parathyroid Hormone; Parathyroidectomy; Renal Dialysis | 1996 |
Effect of CAPD and hemodialysis on parathyroid function.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Bone and Bones; Calcium; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Glands; Parathyroid Hormone; Peritoneal Dialysis, Continuous Ambulatory; Phosphates; Renal Dialysis | 1996 |
Osteodystrophy in a kitten.
Topics: Animal Feed; Animals; Bone Diseases, Metabolic; Calcium Carbonate; Calcium, Dietary; Cat Diseases; Cats; Diet; Hyperparathyroidism, Secondary; Male; Pain; Phosphorus, Dietary; Radiography; Tablets | 1997 |
Long-term effects of intermittent oral alphacalcidol, calcium carbonate and low-calcium dialysis (1.25 mmol L-1) on secondary hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis.
Topics: Albumins; Calcium; Calcium Carbonate; Creatinine; Dialysis Solutions; Female; Glucose; Humans; Hydrogen-Ion Concentration; Hydroxycholecalciferols; Hypercalcemia; Hyperparathyroidism, Secondary; Lactic Acid; Magnesium; Male; Middle Aged; Osmolar Concentration; Peritoneal Dialysis, Continuous Ambulatory; Phosphorus; Time Factors; Treatment Outcome; Urea | 1998 |
Treatment of secondary hyperparathyroidism in hemodialyzed patients with high-dose calcium carbonate without vitamin D3 supplements.
Topics: Administration, Oral; Calcium Carbonate; Cholecalciferol; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Renal Dialysis | 1999 |
Severe ectopic calcification of the intestinal wall in a patient on long-term continuous ambulatory peritoneal dialysis therapy.
Topics: Abdominal Muscles; Calcinosis; Calcium; Calcium Carbonate; Cholecalciferol; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Phosphates; Time Factors; Tomography, X-Ray Computed | 2000 |
Uraemic gangrene syndrome: is parathyroidectomy always necessary?
Topics: Adult; Calcium Carbonate; Gangrene; Humans; Hyperparathyroidism, Secondary; Male; Parathyroidectomy; Syndrome; Uremia | 2001 |
Iatrogenic hypercalcemia in hemodialysis patients.
Topics: Adult; Calcitriol; Calcium Carbonate; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Iatrogenic Disease; Male; Middle Aged; Phosphorus; Renal Dialysis; Risk Factors | 1991 |
Acute effects of calcium carbonate and citrate on secondary hyperparathyroidism in chronic renal failure.
Topics: Calcium; Calcium Carbonate; Citrates; Citric Acid; Female; Gastric Acidity Determination; Humans; Hyperparathyroidism, Secondary; Intestinal Absorption; Kidney Failure, Chronic; Male; Middle Aged | 1991 |
High-dose calcium carbonate with stepwise reduction in dialysate calcium concentration: effective phosphate control and aluminium avoidance in haemodialysis patients.
Topics: Administration, Oral; Adult; Aged; Aluminum; Aluminum Hydroxide; Calcium; Calcium Carbonate; Dialysis Solutions; Drug Administration Schedule; Female; Follow-Up Studies; Hemodialysis Solutions; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Hormone; Phosphates; Renal Dialysis | 1989 |
Effect of one haemodialysis treatment on the plasma concentrations of intact parathyroid hormone and ionised calcium: usefulness of end-dialysis values in evaluating the suppressibility of hyperparathyroidism.
Topics: Adult; Aged; Aluminum Hydroxide; Calcium; Calcium Carbonate; Female; Hemodialysis Solutions; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Hormone; Peptide Fragments; Renal Dialysis | 1989 |
Treatment of secondary hyperparathyroidism in patients on maintenance hemodialysis.
Topics: Adult; Aged; Aluminum Hydroxide; Calcium Carbonate; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Renal Dialysis | 1989 |
Efficacy and safety of long-term treatment with calcium carbonate as a phosphate binder.
Topics: Adult; Aluminum; Aluminum Hydroxide; Blood Chemical Analysis; Calcitriol; Calcium Carbonate; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Long-Term Care; Male; Middle Aged; Phosphates; Renal Dialysis | 1988 |
Oral calcitriol and calcium: efficient therapy for uremic hyperparathyroidism.
Topics: Administration, Oral; Adult; Aged; Calcitriol; Calcium Carbonate; Drug Therapy, Combination; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Uremia | 1988 |
Bone turnover and 1,25-dihydroxycholecalciferol during treatment with phosphate binders.
Topics: Adolescent; Aluminum Hydroxide; Bone Resorption; Calcitriol; Calcium Carbonate; Child; Child, Preschool; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Osteogenesis; Phosphates | 1988 |
The approach to the treatment of secondary hyperparathyroidism in early renal failure.
Topics: Calcitriol; Calcium Carbonate; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic | 1988 |
The influence of a high calcium carbonate intake on bone disease in patients undergoing hemodialysis.
Topics: Administration, Oral; Alkaline Phosphatase; Aluminum Hydroxide; Biopsy; Bone and Bones; Calcification, Physiologic; Calcium; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Osteomalacia; Phosphorus; Radiography; Renal Dialysis | 1973 |